Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures-Reference-Cited by-同舟云学术

Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures

Published:2015-06-01 Issue:8 Volume:35 Page:789-796
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenat Diagn

Author:

Palomaki Glenn E.¹²,Eklund Elizabeth E.¹,Neveux Louis M.¹,Lambert Messerlian Geralyn M.¹²

Affiliation:

1. Division of Medical Screening and Special Testing, Department of Pathology and Laboratory Medicine; Women and Infants Hospital; Providence RI USA

2. Department of Pathology and Laboratory Medicine, Alpert School of Medicine; Brown University; Providence RI USA

Funder

PerkinElmer

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

Reference48 articles.

1. Screening for Down syndrome in the United States: results of surveys in 2011 and 2012;Palomaki;Arch Pathol Lab Med,2013

2. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome;Wald;Prenat Diagn,1997

3. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters;Wald;N Engl J Med,1999

4. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study;Palomaki;Genet Med,2011

5. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18;Ashoor;Am J Obstet Gynecol,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal First-Trimester Alpha-Fetoprotein and Placenta-Mediated Pregnancy Complications;Hypertension;2023-11

2. First-trimester screening for Down syndrome using quadruple maternal biochemical markers;Clinical Chemistry and Laboratory Medicine (CCLM);2023-03-29

3. Newborns in the early neonatal period in a group of mothers at high obstetric and perinatal risk;V.F.Snegirev Archives of Obstetrics and Gynecology;2022-09-23

4. Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects;Genetic Disorders and the Fetus;2021-04-20

5. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies;BMC Pregnancy and Childbirth;2020-11-23